在克隆性血液形成中减轻心血管风险
在PubMed上查看摘要
概括
此摘要是机器生成的。克隆造血 (CHIP) 增加了心血管疾病 (CVD) 的风险. 然而,在具有大型CHIP克隆的个体中,IL-6信号的遗传减少显著降低了这种风险.
科学领域
- 遗传学
- 心脏病学
- 血液学
背景情况
- 不确定潜力的克隆造血 (CHIP) 涉及获得突变的血液造血干细胞的克隆扩张.
- CHIP与心血管疾病 (CVD) 的风险增加有关,特别是心肌梗塞.
- 在CHIP中IL-6和IL-1β的高表达表明IL-6途径是预防心血管疾病的潜在治疗点.
研究的目的
- 调查CHIP与心血管疾病事件之间的关联.
- 确定遗传IL-6通路抑制是否会改变CHIP携带者的心脏病风险.
- 探索CHIP克隆大小对心血管疾病风险及其IL-6信号的改变的影响.
主要方法
- 分析了35,416名没有心血管疾病流行的英国生物库参与者的外体序列数据.
- 基于DNMT3A或TET2等基因突变确定了CHIP状态.
- IL6R p.Asp358Ala编码突变作为IL-6抑制的遗传代理物,并评估其与CHIP发生的心血管疾病的相互作用.
主要成果
- 在3. 0%的参与者中发现了CHIP,更大的克隆 (> 10%的等位基因分数) 导致发生心血管疾病的风险显著增加 (HR, 1.59).
- 在具有大型CHIP克隆的个体中,IL6R p.Asp358Ala变异显著降低了心血管疾病风险 (HR,0. 46).
- 这种降低风险的效果是CHIP携带者特有的,因为没有CHIP的个体没有显著的修改 (P<sub>相互作用</sub>=0. 003).
结论
- CHIP是发生心血管疾病的重要危险因素.
- 基因介导的IL-6信号减少取消了与大型CHIP克隆相关的心血管疾病风险增加.
- 针对IL-6途径可能是预防CHIP患者心血管疾病的新策略.
相关概念视频
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Commitment is the process whereby stem cells:
lose their ability to form all cell types and
irreversibly change into a specific type.
The multipotent hematopoietic stem cells, (HSCs), differentiate into the multipotent hematopoietic progenitor cells, (HPCs). The HPCs express many lineage-specific cytokine receptors. Each of these receptors binds specific cytokines, activates distinct signaling pathways, and expresses a particular gene set. The HPCs further differentiate to...
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

